Ocean Biomedical Valuation
| OCEAW Stock | 0.03 0.0007 2.67% |
Ocean Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Ocean Biomedical from analyzing the company fundamentals such as Total Debt of 12.12 M, number of shares shorted of 39.91 K, and Retained Earnings of (196.06 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ocean Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Ocean Biomedical is based on 3 months time horizon. Increasing Ocean Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ocean stock is determined by what a typical buyer is willing to pay for full or partial control of Ocean Biomedical. Since Ocean Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ocean Stock. However, Ocean Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0255 | Real 0.0245 | Hype 0.03 | Naive 0.021 |
The intrinsic value of Ocean Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ocean Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ocean Biomedical helps investors to forecast how Ocean stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ocean Biomedical more accurately as focusing exclusively on Ocean Biomedical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ocean Biomedical's intrinsic value based on its ongoing forecasts of Ocean Biomedical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ocean Biomedical's closest peers.
Ocean Biomedical Cash |
|
Ocean Valuation Trend
Analysing the historical paterns of Ocean Biomedical's enterprise value and its market capitalization is a good way to estimate and gauge the value of Ocean Biomedical over time and is usually enough for investors to make rational market timing decisions.
Ocean Biomedical Total Value Analysis
Ocean Biomedical is now forecasted to have takeover price of 0 with market capitalization of 0, debt of 12.12 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ocean Biomedical fundamentals before making investing decisions based on enterprise value of the companyOcean Biomedical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Ocean indicates not a very effective usage of assets in January.Ocean Biomedical Profitability Analysis
Net Loss for the year was (114.47 M) with profit before overhead, payroll, taxes, and interest of 0.About Ocean Biomedical Valuation
Our relative valuation model uses a comparative analysis of Ocean Biomedical. We calculate exposure to Ocean Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ocean Biomedical's related companies.Ocean Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ocean Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 34.1 M |
Ocean Biomedical Current Valuation Indicators
Valuation refers to the process of determining the present value of Ocean Biomedical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ocean we look at many different elements of the entity such as Ocean's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ocean Biomedical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ocean Biomedical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ocean Biomedical's worth.Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.